| Patent | Date |
|---|
SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
App 20210023184 - Bookbinder; Louis H. ; et al. | 2021-01-28 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Grant 10,898,551 - Bookbinder , et al. January 26, 2 | 2021-01-26 |
Modified Hyaluronidases And Uses In Treating Hyaluronan-associated Diseases And Conditions
App 20200368330 - Frost; Gregory I. ; et al. | 2020-11-26 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
Grant 10,588,983 - Bookbinder , et al. | 2020-03-17 |
Modified Hyaluronidases And Uses In Treating Hyaluronan-associated Diseases And Conditions
App 20190336587 - Frost; Gregory I. ; et al. | 2019-11-07 |
SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING TH
App 20190224286 - Bookbinder; Louis H. ; et al. | 2019-07-25 |
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
Grant 10,328,130 - Frost , et al. | 2019-06-25 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Grant 10,286,044 - Bookbinder , et al. | 2019-05-14 |
Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects
Grant 10,265,410 - Shepard , et al. | 2019-04-23 |
Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
App 20180185506 - Bookbinder; Louis H. ; et al. | 2018-07-05 |
Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects
Grant 9,878,046 - Shepard , et al. January 30, 2 | 2018-01-30 |
Methods of treatment of collagen-mediated diseases and conditions
Grant 9,833,498 - Keller , et al. December 5, 2 | 2017-12-05 |
Methods of treatment of cellulite
Grant 9,775,889 - Keller , et al. October 3, 2 | 2017-10-03 |
SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
App 20170246264 - BOOKBINDER; Louis H. ; et al. | 2017-08-31 |
Methods for assessing and identifying or evolving conditionally active therapeutic proteins
Grant 9,683,985 - Kodandapani , et al. June 20, 2 | 2017-06-20 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Grant 9,677,061 - Bookbinder , et al. June 13, 2 | 2017-06-13 |
Hyaluronidase and factor VIII compositions
Grant 9,677,062 - Bookbinder , et al. June 13, 2 | 2017-06-13 |
Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)
Grant 9,562,223 - Bookbinder , et al. February 7, 2 | 2017-02-07 |
Adverse Side-effects Associated With Administration Of An Anti-hyaluronan Agent And Methods For Ameliorating Or Preventing The Side-effects
App 20160220690 - Shepard; Harold Michael ; et al. | 2016-08-04 |
Neutral active soluble truncated PH20 polypeptides and uses thereof
Grant 9,284,543 - Wei , et al. March 15, 2 | 2016-03-15 |
Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
App 20160051640 - Bookbinder; Louis H. ; et al. | 2016-02-25 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
Grant 9,211,315 - Bookbinder , et al. December 15, 2 | 2015-12-15 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
App 20150196623 - Bookbinder; Louis H. ; et al. | 2015-07-16 |
Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
App 20150165059 - Bookbinder; Louis H. ; et al. | 2015-06-18 |
Method for control of post-prandial glucose
Grant 9,034,323 - Frost , et al. May 19, 2 | 2015-05-19 |
Modified Anti-epidermal Growth Factor Receptor Antibodies And Methods Of Use Thereof
App 20150071923 - Wei; Ge ; et al. | 2015-03-12 |
Extended soluble PH20 polypeptides and uses thereof
Grant 8,927,249 - Wei , et al. January 6, 2 | 2015-01-06 |
Oncovector Nucleic Acid Molecules and Methods of Use
App 20140350087 - Frost; Gregory I. ; et al. | 2014-11-27 |
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
App 20140341875 - Frost; Gregory I. ; et al. | 2014-11-20 |
In Vivo Temporal Control Of Activatable Matrix-degrading Enzymes
App 20140271609 - Keller; Gilbert ; et al. | 2014-09-18 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
App 20140248237 - Bookbinder; Louis H. ; et al. | 2014-09-04 |
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
Grant 8,815,558 - Frost , et al. August 26, 2 | 2014-08-26 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
App 20140199282 - Bookbinder; Louis ; et al. | 2014-07-17 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Grant 8,772,246 - Bookbinder , et al. July 8, 2 | 2014-07-08 |
Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)
Grant 8,765,685 - Bookbinder , et al. July 1, 2 | 2014-07-01 |
Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
App 20140170159 - Wei; Ge ; et al. | 2014-06-19 |
Super Fast-Acting Insulin Compositions
App 20140135682 - Frost; Gregory I. ; et al. | 2014-05-15 |
Oncovector Nucleic Acid Molecules and Methods of Use
App 20140057969 - Frost; Gregory I. ; et al. | 2014-02-27 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
App 20140037613 - Bookbinder; Louis H. ; et al. | 2014-02-06 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
Grant 8,580,252 - Bookbinder , et al. November 12, 2 | 2013-11-12 |
Super fast-acting insulin compositions
Grant 8,568,713 - Frost , et al. October 29, 2 | 2013-10-29 |
Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
App 20130266579 - Wei; Ge ; et al. | 2013-10-10 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Grant 8,450,470 - Bookbinder , et al. May 28, 2 | 2013-05-28 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Grant 8,431,380 - Bookbinder , et al. April 30, 2 | 2013-04-30 |
Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)
Grant 8,431,124 - Bookbinder , et al. April 30, 2 | 2013-04-30 |
Extended Soluble PH20 Polypeptides and uses thereof
App 20130101577 - Wei; Ge ; et al. | 2013-04-25 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
App 20130058893 - Bookbinder; Louis ; et al. | 2013-03-07 |
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
App 20130028856 - Frost; Gregory I. ; et al. | 2013-01-31 |
Continuous subcutaneous insulin infusion methods with a hyaluronan-degrading enzyme
App 20130022592 - Vaughn; Daniel Edward ; et al. | 2013-01-24 |
Super fast-acting insulin compositions
Grant 8,318,154 - Frost , et al. November 27, 2 | 2012-11-27 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
App 20120294830 - Bookbinder; Louis H. ; et al. | 2012-11-22 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
App 20120251620 - Bookbinder; Louis H. ; et al. | 2012-10-04 |
Super Fast-acting Insulin Compositions
App 20120251517 - Frost; Gregory I. ; et al. | 2012-10-04 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
Grant 8,257,699 - Bookbinder , et al. September 4, 2 | 2012-09-04 |
Extended Soluble PH20 Polypeptides and uses thereof
App 20120213767 - Wei; Ge ; et al. | 2012-08-23 |
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
App 20120171153 - Frost; Gregory I. ; et al. | 2012-07-05 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Grant 8,202,517 - Bookbinder , et al. June 19, 2 | 2012-06-19 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
App 20120148555 - Bookbinder; Louis H. ; et al. | 2012-06-14 |
Methods for assessing and identifying or evolving conditionally active therapeutic proteins
App 20120108455 - Kodandapani; Lalitha ; et al. | 2012-05-03 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
App 20120093770 - Bookbinder; Louis H. ; et al. | 2012-04-19 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
Grant 8,105,586 - Bookbinder , et al. January 31, 2 | 2012-01-31 |
Adverse side-effects associated with administration of anti-hyaluronan agents and methods for ameliorating or preventing the side-effects
App 20120020951 - Shepard; Harold Michael ; et al. | 2012-01-26 |
Myeloid colony stimulating factor and uses thereof
App 20110212074 - Frost; Gregory I. ; et al. | 2011-09-01 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof
App 20110152359 - Bookbinder; Louis H. ; et al. | 2011-06-23 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
Grant 7,871,607 - Bookbinder , et al. January 18, 2 | 2011-01-18 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
App 20110008309 - Bookbinder; Louis H. ; et al. | 2011-01-13 |
Inhibition of Antigen Presentation with Poorly Catabolized Polymers
App 20100331279 - Frost; Gregory I. ; et al. | 2010-12-30 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
Grant 7,846,431 - Bookbinder , et al. December 7, 2 | 2010-12-07 |
Temperature sensitive mutants of matrix metalloproteases and uses thereof
App 20100284995 - Bookbinder; Louis ; et al. | 2010-11-11 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
Grant 7,829,081 - Bookbinder , et al. November 9, 2 | 2010-11-09 |
Human plasma hyaluronidase
Grant 7,781,397 - Stern , et al. August 24, 2 | 2010-08-24 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
App 20100211015 - Bookbinder; Louis H. ; et al. | 2010-08-19 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
App 20100196423 - Bookbinder; Louis H. ; et al. | 2010-08-05 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Grant 7,767,429 - Bookbinder , et al. August 3, 2 | 2010-08-03 |
Myeloid Colony Stimulating Factor and Uses Thereof
App 20100184845 - Frost; Gregory I. ; et al. | 2010-07-22 |
Extended soluble PH20 polypeptides and uses thereof
App 20100143457 - Wei; Ge ; et al. | 2010-06-10 |
Myeloid colony stimulating factor and uses thereof
Grant 7,718,428 - Frost , et al. May 18, 2 | 2010-05-18 |
Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase
App 20100074885 - Schiff; Richard ; et al. | 2010-03-25 |
Human Chondroitinase Glycoprotein (CHASEGP), Process for Preparing the Same, and Pharmaceutical Compositions Comprising Thereof
App 20100015698 - Frost; Gregory I. ; et al. | 2010-01-21 |
In vivo temporal control of activatable matrix-degrading enzymes
App 20100003237 - Keller; Gilbert ; et al. | 2010-01-07 |
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
App 20100003238 - Frost; Gregory I. ; et al. | 2010-01-07 |
Combination therapy using a soluble hyaluronidase and a bisphosphonate
App 20090311237 - Frost; Gregory I. | 2009-12-17 |
Super fast-acting insulin compositions
App 20090304665 - Frost; Gregory I. ; et al. | 2009-12-10 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
App 20090253175 - Bookbinder; Louis H. ; et al. | 2009-10-08 |
Inhibition of Antigen Presentation with Poorly Catabolized Polymers
App 20090215722 - Frost; Gregory I. ; et al. | 2009-08-27 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
App 20090214505 - Bookbinder; Louis H. ; et al. | 2009-08-27 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
App 20090181013 - Bookbinder; Louis H. ; et al. | 2009-07-16 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
App 20090181032 - Bookbinder; Louis H. ; et al. | 2009-07-16 |
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
Grant 7,544,499 - Frost , et al. June 9, 2 | 2009-06-09 |
Inhibition of antigen presentation with poorly catabolized polymers
Grant 7,538,097 - Frost , et al. May 26, 2 | 2009-05-26 |
Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases
App 20090123367 - Bookbinder; Louis H. ; et al. | 2009-05-14 |
Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
App 20070148156 - Frost; Gregory I. ; et al. | 2007-06-28 |
Human Plasma Hyaluronidase
App 20070134228 - STERN; Robert ; et al. | 2007-06-14 |
Use of human plasma hyaluronidase in cancer treatment
Grant 7,148,201 - Stern , et al. December 12, 2 | 2006-12-12 |
Myeloid colony stimulating factor and uses thereof
App 20060247201 - Frost; Gregory I. ; et al. | 2006-11-02 |
Human plasma hyaluronidase
Grant 7,105,330 - Stern , et al. September 12, 2 | 2006-09-12 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
App 20060104968 - Bookbinder; Louis H. ; et al. | 2006-05-18 |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
App 20050260186 - Bookbinder, Louis H. ; et al. | 2005-11-24 |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
App 20040268425 - Bookbinder, Louis H. ; et al. | 2004-12-30 |
Human plasma hyaluronidase
App 20040096921 - Stern, Robert ; et al. | 2004-05-20 |
Inhibition of antigen presentation with poorly catabolized polymers
App 20040047874 - Frost, Gregory I. ; et al. | 2004-03-11 |
Specific inhibitors of hyaluronidase 2, and methods of identifying and using same
Grant 6,682,904 - Frost January 27, 2 | 2004-01-27 |
Myeloid colony stimulating factor and uses thereof
App 20030212021 - Frost, Gregory I. ; et al. | 2003-11-13 |
Use of human plasma hyaluronidase in cancer treatment
App 20030170243 - Stern, Robert ; et al. | 2003-09-11 |
Method of treating tumor-bearing patients with human plasma hyaluronidase
Grant 6,193,963 - Stern , et al. February 27, 2 | 2001-02-27 |
Human urinary hyaluronidase
Grant 6,123,938 - Stern , et al. September 26, 2 | 2000-09-26 |
Hybridoma cell lines producing monoclonal antibodies that bind to human plasma hyaluronidase
Grant 6,103,525 - Stern , et al. August 15, 2 | 2000-08-15 |
BH55 hyaluronidase
Grant 5,827,721 - Stern , et al. October 27, 1 | 1998-10-27 |
| 